10 employees
Wellesley Pharmaceuticals ensures that the ability of Nocturol to reduce and sometimes eliminate nocturia symptoms can be disseminated.
2011
$935K
from 1 investors over 1 rounds
Wellesley Pharmaceuticals LLC raised $935K on February 27, 2015
Investors: Keiretsu Forum Northwest